HighTide Therapeutics, Inc. (HKG:2511)
Hong Kong · Delayed Price · Currency is HKD 3.840
+0.190 (5.21%)
Apr 17, 2026, 4:08 PM HKT
HighTide Therapeutics Market Cap
HighTide Therapeutics has a market cap or net worth of 2.09 billion as of April 17, 2026. Its market cap has increased by 128.87% in one year.
Market Cap
2.09B
Enterprise Value
1.73B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.84
Market Cap Chart
Since December 22, 2023, HighTide Therapeutics's market cap has decreased from 6.37B to 2.09B, a decrease of -67.28%. That is a compound annual growth rate of -38.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 2.19B | 30.17% |
| Dec 31, 2025 | 1.69B | 157.80% |
| Dec 31, 2024 | 653.76M | -90.20% |
| Dec 29, 2023 | 6.67B | 4.68% |
| Dec 22, 2023 | 6.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.13B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 2.61B |
| SinoMab BioScience | 2.34B |
| Immunotech Biopharm | 2.27B |
| Frontage Holdings | 2.09B |
| Mabpharm | 1.79B |
| Cutia Therapeutics | 1.73B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.70B |